7) Medical Countermeasures Initiative
Abstract
The Chem Bio Incident Preparedness and Response-Medical Countermeasures Initiative (CBIPR-MCMI) will integrate advances in regulatory science and flexible manufacturing technologies and processes; and develop animal models and drug discovery and evaluation platforms as enablers of the advanced development of CBDP medical countermeasure products. These initiatives will lead to the establishment of multi-use platforms and animal models that can be leveraged during a CBRN response to accelerate medical product development and/or regulatory approval as well as reduce overall development costs.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2023
- Source ID
- a8b2d242ccff6bd12d70359803f14f19